Methods of using death receptor agonists and EGFR inhibitors

• 收藏
• 分享

专利权人:

Inc.;Genentech

发明人:

Ashkenazi, Avi J.

申请号：

AU2012201321

公开号：

AU2012201321A1

申请日:

2012.03.05

申请国别(地区):

AU

年份:

2012

代理人:

摘要：

#$%^&*AU2012201321A120120329.pdf#####ABSTRACT OF THE DISCLOSURE Methods for using death receptor ligands, such as Apo-2 ligand/TRAIL polypeptides or death receptor antibodies, and EGFR inhibitors to treat pathological conditions such as cancer are 5 provided. Embodiments of the invention include methods of using Apo2L/TRAIL or death receptor antibodies such as DR5 antibodies and DR4 antibodies in combination with EGFR inhibitors, such as TarcevaTm. 3168883 1 (GHMtrters P72533 AU.1

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/